4 Intermittent fasting in the era of obesity pharmacotherapy From a therapeutic perspective, the controversy surrounding the health outcomes of IF should also be considered in the context of the evolving development of novel anti-obesity and anti-diabetic medications
Their evidence base is public: the STEP program studied semaglutide for weight management ( The New England Journal of Medicine , 2021), SURMOUNT studied tirzepatide for weight management (NEJM, 2022), and SURMOUNT-OSA examined tirzepatide in obstructive sleep apnea (NEJM, 2024)
How does Aqualyx work
Your body is getting used to the medication, and doses are usually lower in the beginning
But it belongs in any comprehensive alternative list because clinical situations vary, and sometimes the best option is not the most potent one
How Exercise and Sleep Affect GLP-1 Release Physical activity represents a powerful, evidence-based intervention for enhancing metabolic health